Doyle Mittie
SEC insider (Form 3/4/5 filer). CIK 0001918845. Chief Medical Officer at Avalo Therapeutics, Inc. (AVTX) and 1 other issuer. 41 reported Form 4/5 transactions since Sep 2024; latest on Aug 28, 2026. Located in WAYNE, PA.
Companies Doyle Mittie has filed insider reports for
- Avalo Therapeutics, Inc. (AVTX): Officer, Chief Medical Officer
- Cullinan Therapeutics, Inc. (CGEM): Director
Doyle Mittie
CIK: 0001918845
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (41 total)
- Aug 28, 2026AVTX
Avalo Therapeutics, Inc.
ExerciseDirect679 shares at avg. $8.04$5K - Aug 28, 2026AVTX
Avalo Therapeutics, Inc.
SaleDirect679 shares at avg. $20.00$14K - Aug 17, 2026AVTX
Avalo Therapeutics, Inc.
ExerciseDirect1K shares at avg. $12.65$13K - Aug 17, 2026AVTX
Avalo Therapeutics, Inc.
SaleDirect1K shares at avg. $20.00$20K - Aug 10, 2026AVTX
Avalo Therapeutics, Inc.
SaleDirect679 shares at avg. $20.00$14K - Aug 10, 2026AVTX
Avalo Therapeutics, Inc.
ExerciseDirect679 shares at avg. $8.04$5K - Jul 27, 2026AVTX
Avalo Therapeutics, Inc.
ExerciseDirect1K shares at avg. $12.65$13K - Jul 27, 2026AVTX
Avalo Therapeutics, Inc.
SaleDirect1K shares at avg. $20.00$20K - Jun 30, 2026AVTX
Avalo Therapeutics, Inc.
ExerciseDirect2.9K shares at avg. $12.65$36K - Jun 30, 2026AVTX
Avalo Therapeutics, Inc.
ExerciseDirect1.8K shares at avg. $8.04$14K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 28, 2026 |  AVTX Avalo Therapeutics, Inc. | Exercise | 679 | $8.04 | $5,459 | Direct |
| Aug 28, 2026 | AVTX Avalo Therapeutics, Inc. | Sale | 679 | $20.00 | $13,580 | Direct |
| Aug 17, 2026 | AVTX Avalo Therapeutics, Inc. | Exercise | 1,000 | $12.65 | $12,650 | Direct |
| Aug 17, 2026 | AVTX Avalo Therapeutics, Inc. | Sale | 1,000 | $20.00 | $20,000 | Direct |
| Aug 10, 2026 | AVTX Avalo Therapeutics, Inc. | Sale | 679 | $20.00 | $13,580 | Direct |
| Aug 10, 2026 | AVTX Avalo Therapeutics, Inc. | Exercise | 679 | $8.04 | $5,459 | Direct |
| Jul 27, 2026 | AVTX Avalo Therapeutics, Inc. | Exercise | 1,000 | $12.65 | $12,650 | Direct |
| Jul 27, 2026 | AVTX Avalo Therapeutics, Inc. | Sale | 1,000 | $20.00 | $20,000 | Direct |
| Jun 30, 2026 | AVTX Avalo Therapeutics, Inc. | Exercise | 2,875 | $12.65 | $36,369 | Direct |
| Jun 30, 2026 | AVTX Avalo Therapeutics, Inc. | Exercise | 1,779 | $8.04 | $14,303 | Direct |
1-10 of 41 transactions